In summary, this pan-cancer analysis demonstrated that increased ENO1 expression was correlated with poor prognosis and decreased immune infiltration levels in macrophages, CD4+ T cells, CD8+ T cells, and B cells in CESC and LUAD. This evidence concerns the gene CD4 and cancer.